C
Celgene Corporation was an American biopharmaceutical company focused on the discovery, development, and commercialization of therapeutics for cancer and immunological diseases. It made corporate venture investments in biotech and healthcare startups, and was acquired by Bristol-Myers Squibb in November 2019 for approximately $74 billion.
45% of their portfolio is in Biotech & Life Sciences. They made 1 investment in the last 12 months. Average disclosed round size is $81.9M (across 63 rounds with reported amounts).
Portfolio
50
Fund Size
—
Top Stage
Series B
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
71 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| BBiond Biologics | Series B | $17M | Jun 2026 |
 Human Longevity Inc (HLI) | Series B | $39.8M | Aug 2024 |
 Human Longevity | Series B | $39.8M | Aug 2024 |
 Evelo | Series D | $75M | Aug 2024 |
 Evelo Biosciences | Series D | $75M | Aug 2024 |
| GGRAIL, Inc. | Series B | $900M | Mar 2024 |
 Aadi Bioscience | Series A | $23M | Aug 2021 |
| RRibon | Series B | $65M | Jul 2021 |
 Cyteir Therapeutics | Series B | $40.2M | Oct 2019 |
| GGNS Healthcare | Series D | $23M | Jul 2019 |
 Vividion Therapeutics | Series B | $82M | Apr 2019 |
| AArrakis Therapeutics | Series B | $75M | Apr 2019 |
| VVividion | Series B | $82M | Jan 2019 |
 Arrakis | Series B | $75M | Jan 2019 |
 Antengene | Series B | $120M | Jan 2019 |
 Oncorus, Inc | Series B | $79.5M | Jan 2019 |
| NNantCell | Unknown | — | Dec 2018 |
 Silverback | Series A | $47.5M | Sep 2018 |
| SSilverback Therapeutics | Series A | — | Sep 2018 |
 Sutro Biopharma | Series E | $85.4M | Jul 2018 |
| SSutro Bio | Series E | $85.4M | Jul 2018 |
 Sutro | Series E | $85.4M | Jul 2018 |
 Presage Biosciences | Series D | $13M | Jul 2018 |
 SKYHAWK THERAPEUTICS | Seed | — | Jun 2018 |
| NNohla Therapeutics | Series B | $45M | May 2018 |
Page 1 of 3
Top Co-Investors
Alexandria Venture Investments17 shared
GV16 shared
Amgen Ventures12 shared
Canaan Partners8 shared
ARCH Venture Partners8 shared
The Column Group7 shared
Osage University Partners7 shared
Nextech Invest Ltd.7 shared
Flagship Pioneering7 shared
Alta Partners7 shared
SV Health Investors6 shared
WuXi AppTec5 shared
Kleiner Perkins5 shared
OrbiMed5 shared
Versant Ventures5 shared
Surveyor Capital5 shared
New Enterprise Associates5 shared
Fidelity Investments5 shared
Foresite Capital4 shared
Mayo Clinic4 shared
Last updated: 20 October 2026